While theranostics holds great promise, there are several challenges to be addressed. These include the identification of suitable biomarkers for different cancers, the development of effective targeted therapies, and ensuring that these treatments are affordable and accessible. Additionally, there are regulatory and ethical considerations that must be taken into account.
